Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Valeur

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 20, 2009
Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffoldFranck Lepifre, Serge Christmann-Franck, Didier Roche, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2009
Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type IDidier Roche, Denis Carniato, Caroline Leriche, et al.
Journal of the American Chemical Society|February 15, 2020
Macrocyclic Modalities Combining Peptide Epitopes and Natural Product FragmentsStéphanie M Guéret, Sasikala Thavam, Rodrigo J Carbajo, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type IEric Valeur, Serge Christmann-Franck, Franck Lepifre, et al.
Journal of the American Chemical Society|October 31, 2008
Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interactionChristiane Riedinger, Jane A Endicott, Stuart J Kemp, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2018
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitorsKenji Namoto, Finton Sirockin, Holger Sellner, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Nature Communications|October 28, 2020
A protein tertiary structure mimetic modulator of the Hippo signalling pathwayHélène Adihou, Ranganath Gopalakrishnan, Tim Förster, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Small-molecule factor B inhibitor for the treatment of complement-mediated diseasesAnna Schubart, Karen Anderson, Nello Mainolfi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 20, 2009
Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffoldFranck Lepifre, Serge Christmann-Franck, Didier Roche, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2009
Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type IDidier Roche, Denis Carniato, Caroline Leriche, et al.
Journal of the American Chemical Society|February 15, 2020
Macrocyclic Modalities Combining Peptide Epitopes and Natural Product FragmentsStéphanie M Guéret, Sasikala Thavam, Rodrigo J Carbajo, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Structure-based design of 7-azaindole-pyrrolidine amides as inhibitors of 11β-hydroxysteroid dehydrogenase type IEric Valeur, Serge Christmann-Franck, Franck Lepifre, et al.
Journal of the American Chemical Society|October 31, 2008
Analysis of chemical shift changes reveals the binding modes of isoindolinone inhibitors of the MDM2-p53 interactionChristiane Riedinger, Jane A Endicott, Stuart J Kemp, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2018
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitorsKenji Namoto, Finton Sirockin, Holger Sellner, et al.
Journal of the American Chemical Society|February 24, 2021
Glucagon Like Peptide 1 Receptor Agonists for Targeted Delivery of Antisense Oligonucleotides to Pancreatic Beta CellLaurent Knerr, Thazha P Prakash, Richard Lee, et al.
Nature Communications|October 28, 2020
A protein tertiary structure mimetic modulator of the Hippo signalling pathwayHélène Adihou, Ranganath Gopalakrishnan, Tim Förster, et al.
Journal of Medicinal Chemistry|February 15, 2011
Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein-protein interaction: structure-activity studies leading to improved potencyIan R Hardcastle, Junfeng Liu, Eric Valeur, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2019
Small-molecule factor B inhibitor for the treatment of complement-mediated diseasesAnna Schubart, Karen Anderson, Nello Mainolfi, et al.
Pageof 3